The push for evidence to assist in formulating more effective clinical response to the COVID-19 pandemic is awakening scores of research projects and multipliers more of recommended directions. In the integrative sphere, a team led by Lise Alschuler, ND from the University of Arizona Andrew Weil Center for Integrative Medicine published a paper on “considerations” for natural practices and agents. The Chinese government claims the use of traditional Chinese medicine is in part responsible for its apparently relatively rapid turn-around there. TCM researcher John Chen, PhD, PharmD, OMD, LAc and others have brought that work to the United States. Ryan Bradley, ND, MPH at Helfgott Research Institute led a global team to create a Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry. I helped promote it with this JACM editorial. Yet the US government has been quiet, when not frankly antagonistic to supportive COVID-19 strategies. I connected with the NIH National Center for Complementary and Integrative Health (NCCIH) to see what they are up to related to COVI-19. This column reports the exchange with Helene Langevin, MD, NCCIH’s director.